LON:YGENYourgene Health Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Yourgene Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 18 0.00 (0.00 %) (As of 08/11/2020 09:02 AM ET) Add Compare Share Today's Range 17.93Now: GBX 18▼ 18.2450-Day Range 16.50MA: GBX 17.34▼ 19.5052-Week Range 0.16Now: GBX 18▼ 24.55Volume567,369 shsAverage VolumeN/AMarket Capitalization£112.38 millionP/E Ratio16.36Dividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInsider TradesHeadlines Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. The company is headquartered in Manchester, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Yourgene Health. Previous Next 1.9 Community Rank Outperform VotesYourgene Health has received 17 “outperform” votes. (Add your “outperform” vote.)Underperform VotesYourgene Health has received 27 “underperform” votes. (Add your “underperform” vote.)Community SentimentYourgene Health has received 61.36% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Yourgene Health and other stocks. Vote “Outperform” if you believe YGEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe YGEN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldYourgene Health does not currently pay a dividend.Dividend GrowthYourgene Health does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Yourgene Health insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Yourgene Health is 16.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.48.Price to Earnings Ratio vs. SectorThe P/E ratio of Yourgene Health is 16.36, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.71.Price to Book Value per Share RatioYourgene Health has a P/B Ratio of 4.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.63 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:YGEN Previous Symbol CUSIPN/A CIKN/A Webwww.yourgene-health.com Phone44 16 1667 6865Debt Debt-to-Equity Ratio14.41 Current Ratio2.10 Quick Ratio1.86Price-To-Earnings Trailing P/E Ratio16.36 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£12.71 million Price / Sales8.84 Cash FlowGBX 0.69 per share Price / Cash Flow26.07 Book ValueGBX 3.90 per share Price / Book4.62Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees91 Outstanding Shares624,331,008Market Cap£112.38 million Next Earnings DateN/A OptionableNot Optionable GBX 18 0.00 (0.00 %) (As of 08/11/2020 09:02 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive YGEN News and Ratings via Email Sign-up to receive the latest news and ratings for YGEN and its competitors with MarketBeat's FREE daily newsletter. Yourgene Health (LON:YGEN) Frequently Asked Questions How has Yourgene Health's stock been impacted by COVID-19 (Coronavirus)? Yourgene Health's stock was trading at GBX 14.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, YGEN stock has increased by 22.0% and is now trading at GBX 18. View which stocks have been most impacted by COVID-19. Has Yourgene Health been receiving favorable news coverage? News articles about YGEN stock have been trending neutral this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Yourgene Health earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Yourgene Health. Who are some of Yourgene Health's key competitors? Some companies that are related to Yourgene Health include Renalytix Ai (RENX), Arch Capital Group (AWH), Profound Medical (PRN), Volpara Health Tech (VHT), MaxCyte (MXCT), Exagen (XGN), Akumin (AKU), Palatin Technologies (PTN), Senseonics (SENS), Oncimmune (ONC), Lexagene (LXG), Oncosil Medical (OSL), SQI Diagnostics (SQD), Genedrive (GDR) and BARD1 Life Sciences (BD1). View all competitors. What other stocks do shareholders of Yourgene Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Yourgene Health investors own include Air Liquide (AI), Cerus (CERS), Concepta (CPT), Altyn (ALTN), Alio Gold (ALO), Alamos Gold (AGI), African Gold Group (AGG), Aminex (AEX), Agnico Eagle Mines (AEM) and Adobe (ADBE). Who are Yourgene Health's key executives? Yourgene Health's management team includes the following people: Dr. Stephen Little, Exec. Vice Chairman (Age 62)Mr. Barry Hextall, CFO, Sec. & Exec. DirectorDr. Chia-Han Chan, Chief Scientific Officer & Director (Age 43)Mr. Lyn Fafydd Rees, CEO & Director (Age 46)Mr. Hayden Jeffreys, COO & Director (Age 44) What is Yourgene Health's stock symbol? Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN." How do I buy shares of Yourgene Health? Shares of YGEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Yourgene Health's stock price today? One share of YGEN stock can currently be purchased for approximately GBX 18. How big of a company is Yourgene Health? Yourgene Health has a market capitalization of £112.38 million and generates £12.71 million in revenue each year. Yourgene Health employs 91 workers across the globe. What is Yourgene Health's official website? The official website for Yourgene Health is www.yourgene-health.com. How can I contact Yourgene Health? The company can be reached via phone at 44 16 1667 6865. This page was last updated on 8/11/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
